XML 18 R7.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Noncontrolling Interest
Total
Beginning balance at Dec. 31, 2022 $ 22 $ 1,553,668 $ (829,975) $ (3,722) $ 7,478 $ 727,471
Beginning balance (in shares) at Dec. 31, 2022 222,437,429          
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock   332       332
Issuance of common stock (in shares) 470,351          
Shares withheld related to net share settlement   (175)       (175)
Stock-based compensation   6,096       6,096
Stock-based sales incentive charges   8,172       8,172
Net loss     (38,697)   (135) (38,832)
Other comprehensive income (loss)       705   705
Ending balance at Mar. 31, 2023 $ 22 1,568,093 (868,672) (3,017) 7,343 703,769
Ending balance (in shares) at Mar. 31, 2023 222,907,780          
Beginning balance at Dec. 31, 2022 $ 22 1,553,668 (829,975) (3,722) 7,478 $ 727,471
Beginning balance (in shares) at Dec. 31, 2022 222,437,429          
Increase (Decrease) in Stockholders' Equity            
Repurchase of common stock (in shares)           0
Net loss         (457) $ (81,267)
Other comprehensive income (loss)         0 442
Ending balance at Sep. 30, 2023 $ 22 1,598,634 (910,785) (3,280) 7,021 691,612
Ending balance (in shares) at Sep. 30, 2023 222,987,248          
Beginning balance at Mar. 31, 2023 $ 22 1,568,093 (868,672) (3,017) 7,343 703,769
Beginning balance (in shares) at Mar. 31, 2023 222,907,780          
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock   3       3
Issuance of common stock (in shares) 2,277          
Stock-based compensation   6,093       6,093
Stock-based sales incentive charges   7,820       7,820
Net loss     (16,301)   (185) (16,486)
Other comprehensive income (loss)       1,698   1,698
Ending balance at Jun. 30, 2023 $ 22 1,582,009 (884,973) (1,319) 7,158 702,897
Ending balance (in shares) at Jun. 30, 2023 222,910,057          
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock   284       284
Issuance of common stock (in shares) 77,191          
Stock-based compensation   6,091       6,091
Stock-based sales incentive charges   10,250       10,250
Net loss     (25,812)   (137) (25,949)
Other comprehensive income (loss)       (1,961) 0 (1,961)
Ending balance at Sep. 30, 2023 $ 22 1,598,634 (910,785) (3,280) 7,021 691,612
Ending balance (in shares) at Sep. 30, 2023 222,987,248          
Ending balance at Dec. 31, 2023 $ 22 1,658,339 (929,472) (2,119) 6,877 $ 733,647
Ending balance (in shares) at Dec. 31, 2023 223,026,966         223,026,966
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock   231       $ 231
Issuance of common stock (in shares) 236,089          
Shares withheld related to net share settlement   (304)       (304)
Stock-based compensation   2,629       2,629
Stock-based sales incentive charges   12,897       12,897
Net loss     (18,443)   (173) (18,616)
Other comprehensive income (loss)       (875)   (875)
Ending balance at Mar. 31, 2024 $ 22 1,673,792 (947,915) (2,994) 6,704 729,609
Ending balance (in shares) at Mar. 31, 2024 223,263,055          
Beginning balance at Dec. 31, 2023 $ 22 1,658,339 (929,472) (2,119) 6,877 $ 733,647
Beginning balance (in shares) at Dec. 31, 2023 223,026,966         223,026,966
Increase (Decrease) in Stockholders' Equity            
Repurchase of common stock (in shares)           0
Net loss         (494) $ (53,405)
Other comprehensive income (loss)         0 (389)
Ending balance at Sep. 30, 2024 $ 22 1,709,622 (982,383) (2,508) 6,383 $ 731,136
Ending balance (in shares) at Sep. 30, 2024 223,430,400         223,430,400
Beginning balance at Mar. 31, 2024 $ 22 1,673,792 (947,915) (2,994) 6,704 $ 729,609
Beginning balance (in shares) at Mar. 31, 2024 223,263,055          
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock (in shares) 69,447          
Stock-based compensation   2,862       2,862
Stock-based sales incentive charges   14,079       14,079
Net loss     (16,293)   (174) (16,467)
Other comprehensive income (loss)       (541)   (541)
Issuance of common stock warrants   29       29
Ending balance at Jun. 30, 2024 $ 22 1,690,762 (964,208) (3,535) 6,530 729,571
Ending balance (in shares) at Jun. 30, 2024 223,332,502          
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock   223       223
Issuance of common stock (in shares) 97,898          
Stock-based compensation   2,863       2,863
Stock-based sales incentive charges   15,766       15,766
Net loss     (18,175)   (147) (18,322)
Other comprehensive income (loss)       1,027 0 1,027
Issuance of common stock warrants   8       8
Ending balance at Sep. 30, 2024 $ 22 $ 1,709,622 $ (982,383) $ (2,508) $ 6,383 $ 731,136
Ending balance (in shares) at Sep. 30, 2024 223,430,400         223,430,400